Ignite Creation Date:
2025-12-24 @ 6:47 PM
Ignite Modification Date:
2026-01-16 @ 11:02 AM
Study NCT ID:
NCT02072057
Status:
TERMINATED
Last Update Posted:
2019-02-28
First Post:
2014-02-21
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Study of Ruxolitinib in the Treatment of Cachexia in Patients With Tumor-Associated Chronic Wasting Diseases.
Sponsor:
Kantonsspital Aarau
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
ZOHTNC-02-2013
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None